NOCIL profit and loss

Latest FY26

Revenue: ₹1,303cr−6.4% on FY25
EBITDA: ₹101cr−26.7% on FY25
Net profit: ₹55.6cr−45.9% on FY25
EPS: ₹3.33−46.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	1,476	1,303	1,393	1,445	1,617	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	32.5	36.9	32.1	39.4	6.2
	1,509	1,340	1,425	1,484	1,623
	869	696	798	783	909
	2.3	2.2	2.0	4.0	3.2
	3.0	67.0	−2.6	28.0	−24.3
	97.4	94.2	94.8	92.1	87.5
	1.3	1.4	1.8	1.6	1.2
	55.3	54.9	53.6	52.8	55.7
	375	342	363	342	389
	1,404	1,258	1,311	1,304	1,421
	129	101	137	195	253
	73.8	45.9	83.8	142	197
Profit
	105	81.4	114	180	202
	−5.4	−5.4	0.0	0.0	0.0
	99.7	76.0	114	180	202
	24.1	19.4	28.4	39.9	49.5
	−2.4	1.0	−17.2	7.1	3.5
	21.6	20.4	11.3	47.0	52.9
	78.1	55.6	103	133	149
	78.1	55.6	103	133	149
	−19.2	−13.2	4.3	62.6	5.2
	58.8	42.4	107	196	154
	—	55.6	103	133	149
Per share
	₹4.67	₹3.33	₹6.17	₹7.98	₹8.95
	₹4.66	₹3.32	₹6.15	₹7.95	₹8.92
Other comprehensive income — detail
	−19.2	−13.2	4.3	—	—
	−19.2	−13.0	4.3	62.6	5.2
	—	−0.2	—	—	—
	58.9	42.4	107	196	154
Per share — as-filed variants
	₹4.67	₹3.33	₹6.17	₹7.98	₹8.95
	₹4.66	₹3.32	₹6.15	₹7.95	₹8.92
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	602	537	595	630	729
	40.8%	41.2%	42.7%	43.6%	45.1%
Adjusted (ex-exceptional items) — derived
	105	81.4	114	180	202
	−5.4	−5.4	0.0	0.0	0.0
	82.3	59.6	103	133	149
	₹4.92	₹3.57	₹6.17	₹7.98	₹8.95

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NOCIL₹145.35

NOCIL Limited

· Chemicals

Annual Quarterly₹ CrorePeersHSCL ROSSARI NAVINFLUOR DDEVPLSTIK TATACHEM CHEMPLASTS AARTIIND JGCHEMMcap ₹2,428 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	1,616.6	1,444.7	1,392.7	1,303.0	1,476.1
Other Income	6.2	39.4	32.1	36.9	32.5
Total Income	1,622.8	1,484.0	1,424.8	1,339.9	1,508.6
Expenses
+ Cost of Materials Consumed	908.7	783.0	798.4	696.5	869.2
+ Purchases of Stock-in-Trade	3.2	4.0	2.0	2.2	2.3
+ Changes in Inventories	-24.3	28.0	-2.6	67.0	3.0
+ Employee Benefit Expense	87.5	92.1	94.8	94.2	97.4
+ Finance Costs	1.2	1.6	1.8	1.4	1.3
+ Depreciation & Amortisation	55.7	52.8	53.6	54.9	55.3
+ Other Expenses	388.7	342.5	362.6	342.3	375.1
Total Expenses	1,420.7	1,304.0	1,310.7	1,258.4	1,403.6
EBITDA	252.7	195.0	137.4	100.8	129.1
EBIT	197.1	142.3	83.8	45.9	73.8
Profit
PBT before Exceptional Items	202.1	180.0	114.1	81.4	105.1
+ Exceptional Items	0.0	0.0	0.0	-5.4	-5.4
Pretax Income	202.1	180.0	114.1	76.0	99.7
+ Current Tax	49.5	39.9	28.4	19.4	24.1
+ Deferred Tax	3.5	7.1	-17.2	1.0	-2.4
Tax Expense	52.9	47.0	11.3	20.4	21.6
Net Income	149.2	133.0	102.9	55.6	78.1
+ Net Income — Continuing Ops	149.2	133.0	102.9	55.6	78.1
+ Other Comprehensive Income	5.2	62.6	4.3	-13.2	-19.2
Total Comprehensive Income	154.4	195.6	107.2	42.4	58.8
Net Income to Common	149.2	133.0	102.9	55.6	—
Per Share
Basic EPS	8.95	7.98	6.17	3.33	4.67
Diluted EPS	8.92	7.95	6.15	3.32	4.66
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	4.3	-13.2	-19.2
+ Items NOT to be Reclassified to P&L	5.2	62.6	4.3	-13.0	-19.2
+ Items to be Reclassified to P&L	—	—	—	-0.2	—
Comprehensive Income — Owners of Parent	154.4	195.6	107.2	42.4	58.9
Per Share — as-filed variants
Basic EPS — Continuing Operations	8.95	7.98	6.17	3.33	4.67
Diluted EPS — Continuing Operations	8.92	7.95	6.15	3.32	4.66
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	728.9	629.6	594.8	537.3	601.6
Gross Margin %	45.09	43.58	42.71	41.23	40.76
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	202.1	180.0	114.1	81.4	105.1
− Exceptional Items (reconciliation)	0.0	0.0	0.0	-5.4	-5.4
Net Income Adj (tax-effected)	149.2	133.0	102.9	59.6	82.3
EPS Adj	8.95	7.98	6.17	3.57	4.92
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	166.6	166.7	167.0	167.0	167.0

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.